Explore how AI-driven healthcare solutions are transforming patient care, streamlining workflows, and advancing innovation in collaboration with pharmaceutical and medical device companies.
Alzheimer’s disease affects approximately 8.4 million Americans with mild cognitive impairment (MCI) or mild dementia. There’s new hope for patients...
Aug 13, 2024
In a time of tighter drug prices, extreme competition, and empowered patients, one thing has become clear for biopharma organizations:...
Jul 03, 2024
Every year, too many people with health problems fall through the cracks of a complex care continuum. They go missing—poof—amounting...
Jun 25, 2024
Artificial intelligence (AI) has enormous potential in healthcare, but all too often, it gets misunderstood. Especially with the proliferation of...
Jun 25, 2024
While pharma is increasingly leveraging AI to derive data insights, enhance content development, and inform sales and marketing approaches, there...
Jun 12, 2024
In a span of years—months, really—artificial intelligence (AI) has matured mightily in the public’s eye. Once met with skepticism and...
Apr 23, 2024
Reflecting on Insights from the Reuters Pharma USA Conference In a panel discussion at the Reuters Pharma USA Conference, industry...
Apr 03, 2024
The 2024 J.P. Morgan Healthcare Conference provided a robust platform for leaders, innovators, and disruptors in the healthcare industry to...
Feb 09, 2024
Panelists share their perspectives on how ethically trained AI can combat bias within the healthcare system, leading to greater access...
Mar 31, 2023
